Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bart Frizzell, MD
Wake Forest University, Dept of Radiation Oncology
Principal Investigator - Janet Bull, MD
Four Seasons Hospice and Paliative Care
Principal Investigator - Lynn D Kramer, MD
Par Pharmaceutical, Inc.
Study Chair - Mehool Patel, MD
Summit Oncology Associates, Inc.
Principal Investigator - Veena Charu, MD
Pacific Cancer Medical Center, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pacific Cancer Medical Center, Inc.
Anaheim, California, United States
- Four Seasons Hospice and Paliative Care
Flat Rock, North Carolina, United States
- Wake Forest University
High Point, North Carolina, United States
- Summit Oncology Associates, Inc.
Akron, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 30 Sept 2006
- Completion
- 30 Sept 2006
- Last update posted
- 2 May 2016
- Registered enrollment
- 4
- Registry id
- NCT00637806
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.